^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

KUR-501

i
Other names: KUR-501, CMD-501, CAR-NKT therapy, CAR.GD2-IL-15 NKTs, Chimeric antigen receptors natural killer T-cells (CAR-NKT) therapy, GINAKIT cells, GD2-CAR, GD2-CAR NKT cells, CAR-modified NKT-cell therapy
Associations
Trials
Company:
Athenex, Baylor College of Medicine, Texas Children’s Hospital
Drug class:
GD2 ganglioside inhibitor
Associations
Trials